| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 80 |
| 1 | CYCLOPHOSPHAMIDE | 45 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 45 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 45 |
| 4 | RITUXIMAB | 38 |
| 5 | DOXORUBICIN | 35 |
| 6 | FLUDARABINE PHOSPHATE | 22 |
| 7 | PREDNISONE | 22 |
| 8 | DEXAMETHASONE | 17 |
| 9 | DEXAMETHASONE 1.5 MG | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MENTHOL AND BENZOCAINE | 1 | 0.0185 |
| 1 | GUAIFENESIN AND DEXTROMETHORPHAN HBR | 1 | 0.0105 |
| 2 | IBRITUMOMAB TIUXETAN | 4 | 0.0026 |
| 3 | CORTISOL | 1 | 0.0025 |
| 4 | ETOPOSIDE PHOSPHATE | 3 | 0.0018 |
| 5 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| 6 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 7 | FLUDARABINE PHOSPHATE | 22 | 0.0006 |
| 8 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| 9 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thalidomide Analog [EPC] | 80 |
| 1 | Corticosteroid [EPC] | 46 |
| 2 | Alkylating Drug [EPC] | 45 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 38 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 17 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 6 | Platinum-based Drug [EPC] | 10 |
| 7 | Proteasome Inhibitor [EPC] | 10 |
| 8 | Topoisomerase Inhibitor [EPC] | 9 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 1 | Alkylating Drug [EPC] | 45 | 0.0002 |
| 2 | Thalidomide Analog [EPC] | 80 | 0.0002 |
| 3 | Iron Chelator [EPC] | 4 | 0.0001 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 38 | 0.0001 |
| 6 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 7 | Proteasome Inhibitor [EPC] | 10 | 0.0001 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 4 | 0.0001 |
| 9 | Potassium Binder [EPC] | 1 | 0.0001 |